Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis.
about
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisUpdated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Rituximab for Rheumatoid Arthritis.Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case seriesEfficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunityRituximab in the treatment of pemphigus vulgaris.Review on the influence of protocol design on clinical outcomes in rheumatoid arthritis treated with rituximab.B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.Rituximab for rheumatoid arthrits treatment: a systematic review.The emerging role of rituximab in autoimmune blistering diseases.Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis.Living life without B cells: is repeated B-cell depletion a safe and effective long-term treatment plan for rheumatoid arthritis?The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions.An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial.
P2860
Q26852081-AB959788-CE85-43E8-B2C9-6CFF81DBBD46Q27691388-ADE673E0-985C-475A-9650-B71CD0E13E45Q28080246-F02791E2-04EF-4A42-854D-AD12F879E2F8Q33757209-555E72D7-3213-4B1C-9493-CD78FA13FE74Q34056237-0AAA6C76-0F11-4796-85B4-E0B107C4274CQ35557832-FC45CF03-70F8-499A-B7CE-2913F6DEDE08Q36245714-EFF4303E-90C3-47B4-930F-DE5900FB1732Q36434853-AE95C2D2-4D09-4CF9-A79C-F41E9087DD77Q38085279-4768E45D-2B0E-4815-B490-819C0F0A9D26Q38097129-944FC663-9096-4DF6-B41F-5F2325A7C2B8Q38233120-51FE06F9-0424-46F7-BB1A-A5C99345B88EQ38384497-3449846B-ED8D-45D5-915D-7602915052FDQ38690022-25E41DBF-1381-44A0-9436-BC3A302FB6E0Q38751251-76741B98-67DA-4D2C-9A8D-97D615024D0CQ41593204-0195E5DC-A9F4-43FF-96D3-46D27899B105Q42229459-8D01E382-B612-4676-9C6A-1E18B242F105Q45807880-144650D8-7AB9-427D-B00D-8FD8BF1C1F75Q47831840-DCD54340-5FEE-4FF0-9FDA-77CB3C33567CQ50991407-CC3A777E-B848-4474-A61F-790CB7C2BE22Q52840446-0060B907-202D-41B7-B2C9-978FFDEE06DF
P2860
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Retreatment with rituximab bas ...... retrospective pooled analysis.
@ast
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en-gb
type
label
Retreatment with rituximab bas ...... retrospective pooled analysis.
@ast
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en-gb
prefLabel
Retreatment with rituximab bas ...... retrospective pooled analysis.
@ast
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en-gb
P2093
P2860
P50
P356
P1433
P1476
Retreatment with rituximab bas ...... retrospective pooled analysis.
@en
P2093
Andrea Rubbert-Roth
Helen Tyrrell
Jeffrey R Curtis
Mark Reynard
Norman B Gaylis
Philip J Mease
Sarah Williams
P2860
P304
P356
10.1093/RHEUMATOLOGY/KER253
P577
2011-09-16T00:00:00Z
P5875
P6179
1020302344